LISBON, PORTUGAL (November 10, 2014) - Generics are more than 50% of global prescriptions, equal participation in all aspects of management and standards-setting in International Conference on Harmonization best serves public health.
August 21, 2014 - In a letter sent last week, the International Generic Pharmaceutical Alliance, (IGPA) wrote to the members of the Steering Committee of the International Conference on Harmonization (ICH), seeking the status of an ICH Steering Committee member which would allow it to participate in harmonization of drug quality, safety, efficacy standards equally with the originator industry.
Brussels, 10 December 2013. The International Generic Pharmaceutical Alliance (IGPA) hosted its 16th Annual Conference “A Global Market - A Global Industry”. This event brought together more than 200 representatives from the pharmaceutical industry worldwide, European institutions, national authorities, and high level representatives from the IGPA. Addressing the audience, Laurette Onkelinx, Belgian Deputy Prime Minister and Minister of Social Affairs and Public Health, stressed the invaluable contribution of generic medicines to society stating that the generic medicines sector is a “sustainable industry that can invest in quality”.
- IGPA Letter Regarding TGA Guidance titled “Evaluation of Biosimilars”
- IGPA Statement on the Trans-Pacific Partnership (TPP) Negotiations
- IGPA organizes its annual conference in Brussels in december, registrations are open
- International Generic Pharmaceutical Alliance – IGPA Annual Conference 01st – 03rd November 2011
